APP and Alzheimer disease: In mouse models of AD with mutations in the amyloid precursor protein (APP) or Aβ-producing presenilin, the endosome–autophagosome–lysosome pathway appears dysregulated partly because of impaired acidification of lysosomes that fails to sufficiently activate protease and lipases [26].